E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more

Episode Summary

Executive Summary: The episode centered on a long-form analysis of higher-for-longer rates, the end of capital abundance, and the fallout across IPOs, venture funding, and consumer/enterprise spending. The hosts contrasted broken IPO mechanics with real business fundamentals, debated fiscal and geopolitical risks, and highlighted how AI and automation may reshape labor. They closed with a science corner on a potentially new autoimmune therapy modality.

Main Topics: Higher-for-longer rates and capital scarcity (Priority: 5/5): The hosts argued that the Fed’s messaging confirms a regime change: rates are likely to stay high longer than markets expected, compressing valuations, reducing risk appetite, and forcing startups and VCs to operate with less capital. IPO window, market structure, and private-to-public resets (Priority: 5/5): They dissected recent IPOs (Instacart, Klaviyo, Arm), arguing that low float, weak anchoring, and absent lockups created poor aftermarket dynamics and that the real issue is business performance, not day-one pops. Venture returns, LP behavior, and cap table distress (Priority: 5/5): The discussion focused on LPs shifting away from later-stage venture, demanding earlier entry and clearer edge, while many overfunded unicorns face recapitalizations, dilution, and potential founder wipeout. Consumer and enterprise recession dynamics (Priority: 4/5): The hosts contrasted the earlier B2B/software recession with a potential consumer slowdown driven by high credit-card rates, expensive mortgages, and weak housing mobility, warning that the consumer may now feel the pain. Conference recap and intellectual highlights (Priority: 3/5): They praised All-In Summit 2023 speakers and talks, especially Ray Dalio, Graham Allison, Toby Lutke, Larry Summers, and Bill Gurley, while emphasizing the summit’s optimism and anti-woke editorial posture. Labor pressure, automation, and industrial stress (Priority: 4/5): The hosts debated auto and labor unions, arguing that aggressive wage/work-week demands may weaken legacy automakers and accelerate automation, with Tesla benefiting from structural cost advantages. Science Corner: autoimmune disease therapy breakthrough (Priority: 4/5): A Nature paper was discussed that uses glycosylated antigens delivered to the liver to retrain immune tolerance, potentially opening a new modality for treating autoimmune diseases without broad immunosuppression.

Key Arguments: Higher rates and a delayed cutting cycle will keep discount rates elevated, making growth assets and unprofitable SaaS less valuable for longer. The IPO market is not truly reopening if companies sell too little float, lack anchors, and don’t enforce lockups; those mechanics create a “grand closing,” not a reopening. Private-market overfunding during ZIRP/zero-rate years distorted incentives, leaving many late-stage investors underwater and forcing painful recaps or restructurings. LPs are reallocating toward earlier-stage companies because later-stage venture looks less attractive versus liquid alternatives like treasury or structured credit yields. Consumer spending has held up better than B2B, but high interest costs, mortgage lock-in, and record credit-card debt may now trigger a broader slowdown. Aggressive labor demands in legacy auto could destroy company economics and pension security, while automation and non-union competitors gain relative advantage. The autoimmune therapy approach is promising because it aims to retrain immune tolerance rather than suppress the immune system globally. The summit’s success was framed as being rooted in optimism, first-principles thinking, and substantive debates rather than social-justice signaling.

Data Points: Cold plunge temperature: 56–58°F - One host said he is cold plunging at 56–58 degrees, rejecting the obsession with 45–48 degrees. Body weight record low: 169 lbs - A host mentioned hitting a new record low weight that week. Vivek polling in New Hampshire: 13% - Poll cited during GOP primary discussion; Trump led at 39% with Vivek in second. Trump polling in New Hampshire: 39% - Used to illustrate Vivek’s rise and DeSantis’s decline. DeSantis polling in New Hampshire: 10% - Referenced as part of the Republican primary standings. U.S. debt service: over $1 trillion/year - Used to argue fiscal restraint will be forced by interest costs. Debt refinancing in next 12 months: 30% of U.S. debt - Discussed as refinancing at roughly 5% market rates. All-In Summit 2023 IPO volume through June 30: ~60 billion dollars - EY chart discussed as context for weak IPO activity. All-In Summit 2023 IPO count through June 30: less than 1,200 - Compared with the 2021 peak of 2,400 IPOs. 2021 IPO volume: ~450 billion dollars - Peak year used for comparison with 2023. 2022 IPO volume: ~180 billion dollars - Used as a downshift from 2021. Instacart float: 6.7% - Cited as part of the critique that too little stock was sold. Klaviyo float: 7.6% - Used to show concentrated supply in the IPO. Arm float: 9.4% - Still below the 15–20% float the hosts said should be typical. Instacart revenue growth: 15% YoY - Used when analyzing the business and ad revenue mix. Instacart quarterly revenue: $716 million - Quarter ended June 30. Instacart ad revenue: $206 million - Representing a rapidly growing share of total revenue. Instacart net income: $114 million - Quarter ended June 30. Instacart shoppers: 600,000 - Drivers/shoppers supporting the marketplace. Instacart monthly active orders: 7.7 million - Operational scale discussed in the business analysis. Klaviyo ARR: $650 million - Used to assess SaaS growth and valuation context. Klaviyo growth: 56% YoY - Presented as evidence of strong SaaS performance. Klaviyo net revenue retention: 119% - Used to show strong expansion from existing customers. Klaviyo burn to date: $15 million - Noted as unusually capital efficient. Airtable valuation: $11.7 billion - 2021 Series F valuation cited in the recap discussion. Airtable funding raised: $1.4 billion - Used to argue the pref stack and late-stage financing may exceed current value. Airtable ARR: over $100 million / about $150 million - Transcript gave both figures while discussing growth rate around 15%. Airtable forward price-to-sales: 78x - Calculated from the $11.7B valuation and $150M ARR. Monday.com valuation multiple: ~12x - Used as a public comps comparison. Asana valuation multiple: 6.6x - Used as a public comps comparison. Smartsheet valuation multiple: ~8x - Used as a public comps comparison. Treasury / structured credit yields: 5–13% / 11–13% - Referenced as competing risk-free or lower-risk alternatives to venture. Fed rate-cut odds by May 2024: 29% - Prediction-market estimate used to illustrate delayed easing. Fed rate-cut odds by late 2024: 74% - Prediction-market estimate suggesting cuts are expected later in the year. Oil price: $89/barrel - Used in the inflation/rates discussion.

Pivotal Quotes: "If something can't go on forever, it won't." — Freeberg / attributed to Herb Stein: Used to argue that fiscal and debt dynamics will eventually force restraint. "We have gone from a regime of capital abundance to a regime of capital scarcity." — Sachs: Summarized the post-ZIRP environment and its implications for founders and investors. "The grand reopening was a grand closing." — Chamath: His verdict on the weak IPO structure and poor aftermarket performance of recent tech IPOs.

Implications: Expect fewer IPOs, smaller private rounds, more recaps and consolidation, and tighter startup budgets. Higher rates likely keep pressure on valuations while automation and select businesses with real pricing power become more attractive.